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ABSTRACT
Konakanchi, Deepika Ph.D. The University of Memphis. December 2014. Effects
of Macroscopic Heterogeneity on Cardiac Propagation and Termination of Reentry – A
Simulation Study. Major Professor: Amy de Jongh Curry, Ph.D.
Atrial fibrillation (AF) is believed to be a result of uncontrolled and sustained spiral
wave reentries. Few recent studies have discussed the effect of the heterogeneous nature
of atrial tissue at cellular and microscopic levels, on the electrical activity in the heart and
defibrillation of AF; however, the effect of macroscopic patches of heterogeneity in the
size range of radius 3 – 8 mm has not been studied.
The purpose of this study is to examine the effects of macroscopic patches of
heterogeneity on cardiac propagation and termination of reentry in a computationally
inexpensive, 2D bidomain model of a sheet of cardiac tissue. Tissue heterogeneity was
modeled as a circular area with lower tissue conductivities than the rest of the sheet of
cardiac tissue. Cross-field stimulation was used to initiate sustained single wave reentry.
Termination stimulus, which consisted of a single pulse of varied, amplitude, duration
and timing, was applied via electrodes along two opposite walls of the tissue.
On the introduction of heterogeneous patches with low tissue conductivities, ectopic
activity was observed. Consistent with previous studies, the results show that
heterogeneities favor termination of reentries by splitting the circular reentry into flat
wavefronts that are pushed to the walls of the sheet of tissue and hence annihilated. The
minimum amplitude of the termination stimulus for successful termination of reentry
increased with the size of the patch. Duration and timing of the termination stimulus
were important parameters for successful termination. Patch location played a role in
determining whether or not termination of the spiral wave was achievable. The minimum
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amplitude for successful termination also depended on the size of the stimulation
electrodes.
The study suggests that simplified and computationally inexpensive models can be
insightful tools to better understand the mechanisms that cause AF and hence, more
effective treatment methods.
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PREFACE
The data collected during the project has been organized into two scientific
articles. Chapter 2 entitled “Effects of Macroscopic Heterogeneity on Propagation in a
Computationally Inexpensive 2D Model of the Heart” has been accepted to the 36th
Annual International Conference of the IEEE Engineering in Medicine and Biology
Society. Chapter 3 entitled “Effect of Macroscopic Patches of Heterogeneity on
Termination of Reentry” will be submitted to the Biophysical Journal.
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CHAPTER 1
INTRODUCTION
1.1 Atrial Fibrillation
Atrial fibrillation (AF), the most common cardiac arrhythmia and a major cause of
morbidity and mortality [1], is an important clinical problem affecting over 2.2 million
people in the United States and 4.5 million in the European Union [2]. AF increases the
risk of stroke by 4 to 5 fold [3]. With an increase in the aging population, augmented
occurrences of chronic heart disease and the need for frequent monitoring, there has been
a 66% increase in AF hospitalizations over the last 10 years [2], [4]. Statistical reports
indicate an annual cost of more than $15.7 billion to Medicare, taking into account
hospitalization, workforce and auxiliary procedures related to AF [5]. It is projected that
the number of Americans with AF may increase to more than 12 million by 2050 [6].
Depending on the type of AF and the patient’s history of heart disease, AF is treated
by the use of pharmacological drugs, surgery or external defibrillation. Rate and rhythm
control drugs have potentially serious side effects (e.g. severe to fatal hemorrhaging) and
have success rates of only about 50% [7]. Surgical procedures such as radiofrequency
ablation have success rates of only about 65% and are highly complex [7].
External defibrillation using strong electric shocks is the most common route
followed to restore normal sinus rhythm with success rates of over 90% [8]. However, the
recurrence rate of AF and side effects caused by defibrillation are a concern [9]. Early
recurrence of AF, particularly, in the first 2 weeks after defibrillation is common [10],
despite being subjected to antiarrhythmic drug therapy [11]. Furthermore, 40-60% of
cardioverted patients experience AF again in 3 months and 60-80% in 1 year [11]. The
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side effects of high energy shocks include subtler effects such as pain, myocardial tissue
damage, external scars and more severe effects such as induction of ventricular
fibrillation (VF), bradycardia, complete heart block, increased pacing threshold, atrial
electrical and mechanical dysfunction (stunning), atrial remodeling, reinduction of AF,
initiation of other atrial and ventricular bradycardia and tachycardia, and increased risk of
stroke [12], [13], [14], [8]. Though earlier studies portray the efficacy of internal atrial
defibrillators, where the patient can be shocked on demand, implantable atrial
defibrillators are not used clinically because of the pain and discomfort caused to the
patient by the higher than pain threshold shock strengths [15]–[18].
Although AF is a costly public health problem and its pathophysiology been studied
extensively for over a century, the underlying mechanisms of its genesis and control are
not understood completely [19] . As a result, the current available treatment methods
have significant limitations [20], [21]. There are no long term, effective treatment
methods available without disruption to normal life of a patient with AF.
1.2 Virtual Electrode Polarization
Extensive experimental studies have been carried out on the influence of tissue
discontinuities on propagation velocity and safety of conduction [22]–[24]. Structural
discontinuity has also been attributed to explain the resurrection of normal sinus rhythm
in response to electric shock [25]–[28]. It is believed that tissue heterogeneity behaves
like secondary sources of excitation and results in local polarization which superimposes
on the bulk polarization in the tissue [29], [30]. The heterogeneity provides a substrate for
pinning the reentry and formation of virtual electrodes during defibrillation [31]. This
mechanism is termed as virtual electrode polarization (VEP).
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1.3 Hypothesis
It is well accepted that heterogeneous myocardial tissue contributes to the formation
of reentries and assists defibrillation. Pumir et al. showed experimentally that
heterogeneity at the cellular level had an impact on parameter values which at a
threshold result in ectopic activity [32]. Kuo et al. in their study on the effect of ionic
heterogeneity in specific areas in the atria, crista terminalis, atrioventricular rings, atrial
wall and appendages, found that spiral wave reentry was sustained in the tissue based on
the position and parameter values of the heterogeneity [33]. Cherry et al., in their model
consider heterogeneity in the area of the pulmonary vein (PV)-atrial junction and indicate
that coupling properties critically determine PV reentrant activity [34]. Only recently, the
dimensions of infiltrated atrial fat was measured be in the range of 16 – 83 mm2 [35].
There is no study till date that looks into the role of heterogeneities in this size range and
their effect on formation and termination of reentry.
In this study we hypothesize that macroscopic areas of heterogeneity, such as
infiltrated atrial fat and PV-atrial junction, promote the formation and termination of
reentry. We also believe that their size and position influences reentrant activity. Better
knowledge about the impact of larger areas of heterogeneity can lead the way to the
exploration of lower energy techniques of termination of AF by employing these sites as
virtual electrodes.
1.4 Clinical Application
Direct current cardioversion, using high energy shocks, is the most clinically used
treatment method for patients with AF and it boasts a high success rate. However, the
high energy used is a cause for several side effects such as reinduction of AF [12],
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initiation of other atrial and ventricular bradycardia and tachycardia, increased risk of
stroke [14] and atrial mechanical dysfunction or stunning [13]. Besides, the atria are
more susceptible to electroporation than the ventricles and hence higher energy shock
implies more damage [36]. This calls for the need of low energy methods of atrial
defibrillation. Low energy painless shocks may help in making internal atrial
defibrillators clinically feasible, improve the quality of life in AF patients and help build
smaller devices with longer battery life [37].
Several animal and simulation studies have explored different approaches of multiple
shock, low energy control of electrical chaos in the heart and have shown promising
results [38]–[42]. These studies show that tissue heterogeneity initiates VEP which plays
an important role in low energy defibrillation. Luther et al. demonstrated low energy
termination of fibrillation in adult beagle dogs [38]. They achieved seven times lower
defibrillation thresholds with low energy control than that with standard defibrillation
techniques both in vivo and in vitro for AF and in vitro for VF. According to this study,
the inhomogeneity of myocardial tissue serves as a source of multiple virtual electrodes
that help terminate fibrillation at low energies.
Rantner et al. compared multiple far field stimulation protocols for
cardioversion/defibrillation of VF in a rabbit right ventricle bidomain model [43]. This
model featured cardiac microstructure, such as trabeculations and major coronary vessels.
They studied multiple far field stimuli of strengths above and below the diastolic
activation thresholds. According to their simulations, as the strengths of the stimuli
increased, the number of stimuli required for successful defibrillation decreased, while
the energy required increased. The defibrillation threshold (DFT) in this case was 0.58%
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of the DFT with a single, high voltage biphasic shock, the clinical standard for VF
termination. They also proposed a novel, 2-stage low-voltage defibrillation protocol for
VF. This further lowered the DFT to 57.42%, as compared to energy required at 88% of
the VF cycle length (CL) rate [43]. Rantner et al. studied the effect of VEP on
defibrillation and found that new VEP-induced wavefronts, which originated in the
trabecular grooves, collided with the original arrhythmia wavefront, resulting in its
termination.
Ambrosi et al. compared anti-tachycardia pacing , low voltage multiple shock therapy
and single phase-independent shocks for AF and atrial flutter in vitro in a rabbit whole
heart model [39]. The DFT was significantly decreased when using low voltage multiple
shocks as compared to conventional single shocks. The successful termination of
reentries using the low energy technique was attributed to the recruitment of an adequate
number of virtual electrodes resulting from tissue heterogeneity.
Li et al. experimented on a similar multiple shock technique for ventricular
tachycardia in vitro on rabbit hearts [42]. This study concluded that a 3-stage
cardioversion therapy lowers the required energy for the successful termination of AF.
The first stage shock produces VEP at tissue heterogeneity locations to unpin reentry
from the resistive heterogeneity. The second, anti-repinning stage prevents the
meandering reentries from attaching back to the tissue heterogeneities. The third, antitachycardia pacing stage drives the remaining reentries to the boundaries, annihilating
them. Here again, tissue heterogeneity promotes lowering defibrillation energy.
Fenton et al. studied low energy, far field stimulation for the termination of fast atrial
tachycardia and AF in excised canine atrial tissue [41]. In this method, the electrodes
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were proposed to be located at a small distance outside the heart and the field applied
resulted in virtual electrodes at tissue inhomogeneities (collagenous septa and
conductivity discontinuities at gap junctions to represent plaque between fibers in older
hearts) [41]. These virtual electrodes served as secondary excitation sources, if the field
strength was above the excitation threshold [25]. With sufficient applied field strength,
more than one virtual electrode was recruited to entrain the entire tissue and hence
terminate arrhythmia. The greater the number of virtual electrodes, the lesser was the
time required to excite the myocardial preparation. They observed a 91% reduction in
energy required for successful defibrillation using this technique when compared to
single shock defibrillation. Furthermore, the average energy for successful termination
was lower than the energy at which sedation is required while shocking [41].
It is clear from all these studies that low energy multiple shock therapies are effective
in activating virtual electrodes at tissue heterogeneities and is a promising approach to
terminate AF at lower defibrillation thresholds. If effective multiple low energy shocks
result in combined energies lower than the perceivable pain threshold, internal atrial
defibrillators can become clinically feasible devices for AF treatment. Thus the study of
the effect of tissue heterogeneities of different sizes and properties on propagation and
defibrillation will pave the way towards more efficient and less harmful defibrillation
techniques for AF.
With experimental studies it is practically impossible to detect the formation of
virtual electrodes and their role in the formation and termination of arrhythmia.
Furthermore, it is extremely difficult to simultaneously track ion channels, action
potential and tissue heterogeneity and their effect on the intrinsic electrical properties of
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the atria, inception and propagation of reentry and therapeutic shock waves,
experimentally or clinically, because of the complexity of the mechanism itself and
cardiac microstructure [44]. Computational models are thus essential tools in developing
the basic understanding of such complex mechanisms.
1.5 Objectives
The dynamics of the formation and termination of AF wavefronts are difficult to
decipher using experimental studies [45]. Several computational models have been
developed over the past two decades to study the factors that influence the genesis and
control of fibrillation for a better understanding of the underlying mechanisms [38], [40],
[45]–[53]. The purpose of this project is to study the effect of macroscopic patches of
heterogeneity on the action potential propagation and termination of reentry.
The objectives of this study are:
1. To construct a 2D bidomain action potential propagation model of cardiac
tissue and study the effects of macroscopic patches of heterogeneity on
propagation.
2. To simulate reentry in the model and determine whether or not macroscopic
patches of heterogeneity support the defibrillation process.
3. To analyze the effects of size and position of patches, size of stimulation
electrodes, amplitude of the termination stimulus and anisotropy on
termination of reentry.
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CHAPTER 2
EFFECT OF MACROSCOPIC PATCHES OF HETEROGENEITY ON
PROPAGATION
2.1 Introduction
Tissue discontinuities in the myocardium affect propagation of cardiac impulses [1].
These discontinuities can be a result of the essentially heterogeneous nature of heart
tissue, such as the existence of coronary vasculature or abnormalities, such as infiltrated
atrial fat, fibrosis, scars, and ischemic regions which vary in size and structure [1]. In a
healthy heart, these heterogeneities may not have any significant impact on cardiac
function and activity; however, on the application of external electric fields or in a
diseased condition, heterogeneities can induce ectopic activity and formation of virtual
electrodes [2]–[4]. Though it is known that these ectopic foci or virtual electrodes play a
significant role in the genesis and termination of arrhythmia [5], the specific mechanisms
of the interaction between propagation, tissue heterogeneities and applied external field is
yet to be understood.
In a study by Pumir et al., the effect of heterogeneity was examined at the cellular
level experimentally using neonatal rat cardiomyocytes. A small region was subjected to
an ischemic environment to find out if these group of cells spontaneously depolarize and
affect the surrounding network of cells. They also conducted modeling studies with a
numerical model where heterogeneity was represented by a random distribution of
cellular properties. This study showed that heterogeneity had an impact on parameter
values which at a threshold result in ectopic activity. The size and spatial distribution of
cellular heterogeneity was observed to affect propagation. They also concluded that
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heterogeneity decreases automaticity threshold and hence small disturbances in the
environment result in ectopic behavior [2].
Kuo et al. developed 2D and quasi-3D simulation models to analyze the effect of
ionic heterogeneity [6]. The specific areas in the atria considered as heterogeneous tissue
were crista terminalis, atrioventricular rings, atrial wall and appendages [6]. They found
that the longevity of the spiral wave reentry was sustained in the CT for the longest time
because of its position and long action potential duration [6].
In another study by Cherry et al., cell to cell connections were removed to model
heterogeneity in the area of the pulmonary vein (PV)-atrial junction and a larger
anisotropy ratio was set in the heterogeneous region as compared to the rest of the tissue.
They found that both the larger arrhythmogenic PV size and coupling properties critically
determine PV reentrant activity [7].
Calvo et al. studied the heterogeneous distribution of transmembrane currents at the
PV-left atrial junction and found that the ionic current heterogeneity is a cause for the
drift of rotors towards the junction and also a mechanism driving paroxysmal atrial
fibrillation (AF) [8].
Infiltrated atrial fat, in recent years, has been considered as a risk factor associated
with atrial fibrillation (AF) [9]–[11]. Tereshchenko et al. in the early part of 2014, have
been able to quantitatively measure for the first time, the amount of infiltrated atrial fat to
be in the range of 16 – 83 mm2 in a study group of 90 patients, using recently developed
novel fat-water-separated MRI imaging techniques, [12]. They were able to associate the
amount of infiltrated fat with an independently assigned AF risk score and stated that it
monotonically increased with risk of developing AF [12]. Though previous modeling
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studies have studied the role of cellular, ionic and microstructural heterogeneities [13],
there is no computationally inexpensive simulation model of the heart that has studied the
role of macroscopic heterogeneities, such as infiltrated atrial fat and PV-atrial junction on
propagation. These easy to replicate cardiac models may be sufficient as a first step to
understand the electrical mechanisms that lead to arrhythmia [14]–[17].
The purpose of this study is to determine the effect of macroscopic atrial tissue
heterogeneities on propagation and hence conditions such as AF in a 2D bidomain model
of cardiac tissue.
2.2 Methods
The electrical activity in the heart was represented by the bidomain model in
conjunction with the modified Fitz-Hugh Nagumo equations in a 2D sheet of cardiac
tissue with areas designated to represent the sino-atrial node (SAN) and atria.
2.2.1 Model Equations
The bidomain equations are the most widely used system of partial differential
equations to represent cellular activation in cardiac tissue [18]. The bidomain model was
chosen for this study so that the combined effect of varied anisotropy ratios in the
extracellular and intracellular domains and heterogeneous conductivities on propagation
can be realized. The bidomain equations were implemented along with the modified
FitzHugh-Nagumo equations to represent cellular ion kinetics as in a previous study [15].
The model equations are represented by equations 1, 2 and 3.

𝜕𝑉𝑒 𝜕𝑉𝑖
−
+ ∇ ∙ (−𝜎𝑒 ∇𝑉𝑒 ) = 𝑖𝑖𝑜𝑛
𝜕𝑡
𝜕𝑡
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𝜕𝑉𝑖 𝜕𝑉𝑒
−
+ ∇ ∙ (−𝜎𝑖 ∇𝑉𝑖 ) = −𝑖𝑖𝑜𝑛
𝜕𝑡
𝜕𝑡

(1)

𝜕𝑢
(𝑉𝑚 − 𝐵)
= 𝑘𝑒 [
− 𝑑𝑢 − 𝑏]
𝜕𝑡
𝐴

Ve and Vi are the dependent variables that represent extracellular and intracellular
potentials respectively, Vm = Vi – Ve is the transmembrane potential and u is the recovery
variable that represents cellular refractoriness. σe and σi are the extracellular and
intracellular conductivities respectively. a, b, c1, c2, c3, d, e, k, A and B are regionspecific parameters. iion is the ionic current, and is defined by different quantities in the
SAN and the rest of the tissue to enable sustained and auto-initiated impulses in the SAN.
iion was calculated as

𝑖𝑖𝑜𝑛 = 𝑘𝑐1 (𝑉𝑚 − 𝐵) [𝑎 −

(𝑉𝑚 − 𝐵)
(𝑉𝑚 − 𝐵)
] [1 −
] + 𝑘𝑐2 𝑢
𝐴
𝐴

(2)

(𝑉𝑚 − 𝐵)
(𝑉𝑚 − 𝐵)
] [1 −
] + 𝑘𝑐2 𝑢(𝑉𝑚 − 𝐵)
𝐴
𝐴

(3)

within the SAN, and,

𝑖𝑖𝑜𝑛 = 𝑘𝑐1 (𝑉𝑚 − 𝐵) [𝑎 −

in the rest of the tissue. The conductivity values and parameters were chosen as in the
previous study by Sovilj et al. [15].
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2.2.2 Geometry
The geometry consists of a sheet of tissue of dimensions 40 mm x 40 mm as shown in
figure 2-1. The SAN and atrial regions are differentiated from each other in the model by
altering model parameters in each of the regions [15] and via expressions (2) and (3).
Note that atrial regions R1 and R2 are assigned the same model parameters, and are
delineated for purposes of identifying atrial regions with and without heterogeneous
patches. The dimensions of the three regions were chosen arbitrarily. In this study we
assume the fibers are straight and aligned parallel to cartesian x-axis. Low conductivity
values were assigned to heterogeneous patches, depicted by VE1, VE2 and VE3 in figure
2-1, which represent cardiac tissue heterogeneities such as infiltrated atrial fat. Several
studies have recognized that these heterogeneities act as virtual electrodes or ectopic foci
and play an important role in the genesis and termination of cardiac arrhythmia [3], [5],
[19], [20].
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Figure 2.1: 2D geometry consists of a 40 mm x 40 mm sheet: including areas designated
as SAN, atrium R1 and atrium R2. VE1, VE2 and VE3 represent three heterogeneous
patches.
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2.2.3 Model Execution
The purpose of this study is to simulate the effect of heterogeneous patches on
propagation in atrial tissue. Model parameters were chosen to simulate sustained normal
propagation with wave-fronts auto-generated in the SAN and transmitted to the atria
continuously without external stimulation, as in a previous study by Sovilj et al. [15].
Zero flux boundary conditions were used along all external boundaries in the intercellular
space. In the extracellular space all external boundaries except the right edge (designated
as ground as shown in figure 2-1) were subjected to zero flux boundary conditions.
Though there is no consensus on the actual values of tissue conductivities, previous
studies discuss that conductivity ratios in the planes along and across the fiber direction
in the two domains are different and this phenomenon affects propagation [21] and hence
anisotropic tissue conductivities were used. Table 2-1 lists the assigned values of tissue
conductivities used in the model.
The simulations were carried out using COMSOL Multiphysics v4.3b package for
finite element analysis, on an Intel core i7-XPS 8100 PC with a processor speed of 2.93
GHz. The mesh used consisted of 2038 mesh elements to represent the total area of 1600
mm2. The maximum element size was 1.48 mm in the homogeneous tissue. The
simulation time for each execution of the model was about 20 minutes. Further reduction
in mesh size did not change the spatial distribution of Vm.
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Table 2.1: Anisotropic Tissue Conductivity Values
σex (mS/m)a

σey (mS/m)

σix (mS/m)

σiy (mS/m)

SAN

0.4

0.2

0.5

0.05

Atria
(R1 & R2)

6

4

8

0.8

VE1
VE2
VE3

3e-4
4e-7
8e-7

1.5e-4
2e-8
4e-8

1e-4
1e-7
1e-8

1e-5
1e-8
1e-9

a. In the notation for conductivity values, σex, σey, σix and σiy, the 1st subscript denotes
extracellular or intracellular and the 2nd subscript denotes direction; x implies along, and
y across the fiber direction, respectively [15].

2.3 Results and Discussion
Simulations were carried out using a 2D geometry with areas designated to represent
the SAN and atria with and without heterogeneous regions. The model parameters were
varied to study the effect of heterogeneity on the rate and rhythm of propagation. Patches
with heterogeneous tissue conductivities were introduced to represent regions known to
be responsible for the formation of ectopic foci and virtual electrodes in the atria, such as,
fatty tissue, scar tissue and coronary vasculature [5], [20], [22], [23].
2.3.1 Effect of heterogeneity on propagation
Figure 2-2 displays the case of normal propagation with no heterogeneous patches.
Figures 2-2(A) and 2-2(B) show the spatial distribution of Vm at times, 0.55 s and 0.7 s,
respectively. The wave front initiated in the SAN is propagated uniformly to the atria.
Figure 2-2(C) shows the transmembrane potential, Vm, over a span of 5 seconds in the
case of homogeneous tissue throughout the atria. The cycle length (CL) is ~ 700 ms and
the rhythm is regular. The impulses generated in the SAN (solid blue tracing, measured at
(5,5) mm) are propagated to the atrium R1 (dotted red tracing, measured at (20,20) mm)
15

and atrium R2 (dashed black tracing, measured at (35,35) mm) in a regular manner. Note
that for every impulse generated in the R1 and R2 regions (dotted red and dashed black
tracing) there is a corresponding impulse in the SAN (solid blue tracing), i.e. the
propagation in the atrial tissue follows the SAN.
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Figure 2.2: Normal propagation without heterogeneous patches. (A) & (B) Spatial
distribution of transmembrane potential (Vm) at t= 0.55 and 0.7 s, respectively; (C)
Measurement of Vm at spatial coordinates (5,5), (20,20) and (35,35) mm in the geometry
representative of electrical activity in the SAN, atrium R1 and atrium R2, respectively;
CL = ~700 ms.
17

Figure 2-3 displays action potential propagation with the introduction of
heterogeneity in the atrial tissue. Figures 2-3(A) and 2-3(B) show the spatial distribution
of transmembrane potential, Vm, at 1.5 s and 1.59 s respectively. Figure 2-3(C) is a plot
of transmembrane potential,Vm, measured at spatial coordinates (5,5), (20,20) and (35,35)
mm in the geometry representative of electrical activity in the SAN, atrium R1 and
atrium R2, respectively; the CL is about 550 ms.
In figure 2-3(C) there are impulses in the atrial region (dotted red and dashed black
line) at 1.75 s and 4.1 s without a corresponding SAN impulse (solid blue line). These
impulses are the ectopic beats originating in the atria because of the heterogeneous
patches. This is also visible in figure 2-3(B): when the three square heterogeneous
patches are polarized, R1 region starts to polarize while the SAN area is still depolarized,
corresponding to the impulse at 1.75s in figure 2-3(C).
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Figure 2.3: Effect of heterogeneity on propagation. (A) Spatial distribution of Vm at
t=1.5 s; Formation of ectopic foci in the region of the heterogeneity patches. (B) Spatial
distribution of Vm at t=1.59 s. (C) Measurement of Vm at spatial coordinates (5,5),
(20,20) and (35,35) mm in the geometry representative of electrical activity in the SAN,
atrium R1 and atrium R2, respectively; Irregular and faster paced propagation with the
introduction of heterogeneous patches; CL = ~ 550 ms.
19

2.3.2 Effect of conductivity ratio
In this simulation setup, the geometry consisted of a single circular heterogeneity
patch of radius 6 mm at the center of a 100 mm x 100 mm sheet of cardiac tissue (figure
2-4(A)) to analyze the effect of heterogeneity, exclusively. The conductivity values in the
heterogeneous patch were varied to determine if there is a minimum difference in
conductivity between the heterogeneous patch and the rest of the normal atrial tissue
required to observe ectopic activity. Figures 2-4(B) and 2-4(C) plot the transmembrane
potential, Vm, over time for homogeneous and heterogeneous tissue respectively. While
in figure 2-4(B), every impulse generated in the atria follows that generated in the SAN,
in figure 2-4(C), at t = 0.9 s, for example, an impulse is observed in the atrial region (red
dotted tracing) without a corresponding impulse in the SAN area (blue solid tracing).
When the heterogeneity ratio σpatch/ σatria was varied in directions along and perpendicular
to the myocardial fiber in both the extracellular and intracellular domains (anisotropic
conductivities), ectopic beats were observed only when the ratio when σpatch/ σatria <=
10-3. When the ratio was greater than 10-3 the transmembrane potential in the atrial tissue
looked identical to normal propagation in the absence of heterogeneities. Figure 2-4(D)
shows the spatial distribution of transmembrane potential at 0.72 s representative of
activity due to normal impulses generated in the SAN and transmitted to the rest of the
tissue and fig 2-4(E) at 0.98 s representative of ectopic impulses generated in the atria
due to the heterogeneous patches.
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Figure 2-4: Effect of conductivity ratio on propagation. (A) 2D geometry consists of a
100 mm x 100 mm sheet with a patch of heterogeneity of radius 6mm with patch centroid
at (0,0) mm. (B) Measurement of Vm when σpatch/ σatria > 10-3 in the SAN at spatial
coordinates (-30,-30), and the atrium at (35,35) mm. (C) Measurement of Vm when σpatch/
σatria <= 10-3 in the SAN at spatial coordinates (-30,-30), and the atrium at (35,35) mm.
Ectopic beats occur in the atrial region without a corresponding impulse generated in the
SAN. (D) Spatial distribution of Vm at t=0.72 s due to normal propagation. (E) Spatial
distribution of Vm at t=0.98 s due to ectopic activity.
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The novelty of this simulation model is the demonstration of ectopic activity during
propagation as a result of macroscopic heterogeneity in a computationally efficient and
inexpensive model, as a basis for future studies. The rhythm and/or pace were affected
with the introduction of patches of low tissue conductivity in atrial tissue, resulting in
ectopic activity. This was achievable with the use of a simplistic numerical model to
represent ionic currents.
The limitation of this study is the use of a low resolution geometry as compared to
studies that incorporate detailed and complex microstructure in their geometry [3], [24],
[25]. Furthermore we use a simple Fitz-Hugh Nagumo model to represent atrial ion
kinetics versus realistic ionic models, such as, the Courtemanche et al. model or the more
recent model by Grandi et al. which includes intracellular Ca2+ handling, known to be a
key mediator in AF pathophysiology [26], [27]. The reason for this approach of using
simple geometry and ionic model are: (1) to obtain a clear understanding of the effect of
heterogeneous tissue prior to adding layers of complexity and (2) to create a
computationally inexpensive and efficient model.
2.4 Conclusions
We have been able to show with this model that a simple 2D model is sufficient to
simulate ectopic activity in atrial tissue as a result of macroscopic heterogeneities, such
as, infiltrated fat. The results also indicate that a minimum conductivity gradient is
required between the patch and the rest of the surrounding tissue to be able to observe
ectopic activity.
This model is a novel framework of a computationally inexpensive model for further
studies on the role of heterogeneities in the genesis and termination of atrial arrhythmia.
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AF is an important clinical problem and the number of patients suffering from AF is
increasing with the aging population. Further studies with models incorporating detailed
geometries may help predict the risk of AF in people with normal SR by analyzing the
location and type of heterogeneity in atrial tissue and hence effect on fibrillation.
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CHAPTER 3
EFFECT OF MACROSCOPIC PATCHES OF HETEROGENEITY ON
TERMINATION OF REENTRY
3.1 Introduction
Atrial Fibrillation (AF) is the most common cardiac arrhythmia and a major cause of
morbidity and mortality [1]. Hospital admissions for cases of AF have considerably
increased over the years as a result of aging of the population, augmented occurrences of
chronic heart disease and the need for frequent monitoring [2]. Depending on the type of
AF and the patient’s history of heart disease, AF is treated by the use of pharmacological
drugs, surgery or external DCC. Rate and rhythm control drugs have potentially serious
side effects (e.g. severe to fatal hemorrhaging) and have success rates of only about 50%
[3]. Surgical procedures like radiofrequency ablation have success rates of about 65%
and are highly complex [3]. Thus DCC is the most widely used technique with success
rates of 97% [4].
Despite the fact that cardiac defibrillation is clinically a very important, extensively
used technique and several decades of experimental and theoretical studies have gone
into studying defibrillation, the fundamental mechanisms on which electrical shocks
terminate arrhythmia is not completely understood. The widely accepted theory is that the
microscopic and macroscopic heterogeneities in the myocardial tissue play an important
role in the genesis and annihilation of fibrillatory effects [5]–[15]. This mechanism,
termed as virtual electrode polarization (VEP) states that tissue discontinuities, such as,
gap junctions, blood vessels, intercellular clefts and fibrosis behave as ectopic or
secondary sources of excitation, where the electrode-tissue interface is the primary
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source. VEP results in depolarization at localized areas in the tissue, affecting a critical
mass of the tissue and hence defibrillation [6], [8], [16]–[18].
Keener et al. in their defibrillation model included variations in resistivity at the
cellular level and showed that, the resistive inhomogeneities assisted in the transmission
of a depolarizing bias as a result of external stimulus to the entire excitable tissue
responsible for defibrillation [18] . In another study in the early years of research on the
role of tissue inhomogeneties in defibrillation, Trayanova and coworkers showed that the
fibrous organization of the myocardium plays a significant role [9]. The applied shock
caused changes in transmembrane potential in the bulk tissue as a result of the curved
pathways of individual fibers and fiber rotation across the ventricular wall [9]. Localized
polarization was also observed around the fibrous structures which superimposed the
large-scale effect of the shock [9]. They confirmed that virtual electrodes formed in the
bulk tissue as a result of an applied shock are of opposite polarity to the rest of the tissue
and is a key to success of the defibrillation shock [10].
Ashihara et al. studied the effect of electroporation as a source of heterogeneity in
myocardial tissue and its effect of defibrillation [11]. High energy defibrillation shock
extinguished ongoing fibrillation with and without electroporation [11]. However, new
spiral waves were initiated in the non-electroporating tissue, while no new reentrant
activity resulted post shock in the electroporating tissue [11]. Hooks et al., in their study
on the effect of structural heterogeneities on defibrillation, concluded that interlaminar
clefts between layers of myocardial cells in the ventricles serve as a substrate for
secondary localized activation [12]. Bishop et al. showed that coronary vasculature
contribute to the formation of virtual electrodes during external field stimulation [15].
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The impact of heterogeneities on defibrillation at cellular and microscopic levels has
been explored in several previous studies. Recent publications discuss the role of
macroscopic sources of heterogeneity in atrial tissue, such as, pulmonary vein – atrial
junction, crista terminalis and appendages on atrial reentry [19]–[21]. These larger
regions of discontinuity besides being a hub for the formation of reentries are also
believed to attract rotors created elsewhere and anchor them [19], [21]. Further, earlier in
2014, Tereshchenko et al. have been able to quantitatively measure for the first time, the
amount of infiltrated atrial fat to be in the range of 16 – 83 mm2 in a study group of 90
patients, using recently developed novel fat-water-separated MRI imaging techniques,
[22]. They were able to associate the amount of infiltrated fat with an independently
assigned AF risk score and stated that it monotonically increased with risk of developing
AF [22]. Fat tissue definitely has different electrical properties compared to the rest of the
highly conductive atrial myocardium and hence can be treated as a source of tissue
heterogeneity. There is no study till date that has looked into the effect of these
macroscopic sources of heterogeneity, with radii in the order of a few millimeters, on
defibrillation.
Our study aims to examine the effect of macroscopic sources of tissue heterogeneity
on termination of reentry in a 2D, computationally inexpensive, bidomian model of
cardiac tissue. We study the impact of size of heterogeneity patch and stimulation
electrodes, duration and timing of termination stimulus, equal and unequal anisotropy
ratios, smooth and sharp transitions of conductivities in the patches of heterogeneity on
termination of reentry.
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3.2 Methods
In this computational study, the effect of macroscopic patches of heterogeneity on
termination of reentry was analyzed with a finite element model of a sheet of cardiac
tissue. Simulations were carried out to determine whether larger heterogeneities
facilitated or hindered termination of sustained reentry. The effect of size and location of
heterogeneity, size of stimulation electrodes, equal and unequal anisotropy ratios, smooth
and sharp transitions of tissue conductivity, and, duration and timing of termination
stimulus on the termination of spiral wave were examined.
3.2.1 Model description
The cellular activation in the heart was modeled in a 100 mm x 100 mm square which
represented a sheet of cardiac tissue, using the bidomain equations in conjunction with
the FitzHugh Nagumo equations [23], [24]. According to the bidomain theory, heart
tissue is a functional syncytium of two interpenetrating, overlapping regions, namely, the
intracellular and extracellular domains which are separated by the cell membrane [25].
The electrical properties of the heart have been studied for the past two decades using this
theory, where each of the domains and the cell membrane are modeled as a
resistive/capacitive network [26]. The equations (1) below solve for three dependent
variables, namely, the extracellular potential, Ve, the intracellular potential, Vi, and the
recovery variable, u, which represents cellular refractoriness. Vm, the transmembrane
potential is calculated as Vm = Vi - Ve.

𝜕𝑉𝑒 𝜕𝑉𝑖
−
+ 𝛻 ∙ (−𝜎𝑒 𝛻𝑉𝑒 ) = 𝑖𝑖𝑜𝑛 + 𝐼𝑒𝑥𝑡
𝜕𝑡
𝜕𝑡
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𝜕𝑉𝑖 𝜕𝑉𝑒
−
+ 𝛻 ∙ (−𝜎𝑖 𝛻𝑉𝑖 ) = −𝑖𝑖𝑜𝑛
𝜕𝑡
𝜕𝑡

(1)

𝜕𝑢
(𝑉𝑚 − 𝐵)
= 𝑘𝑒 [
− 𝑑𝑢 − 𝑏]
𝜕𝑡
𝐴

σe and σi are the extracellular and intracellular conductivities. I_ext is the external
stimulus and iion is the ionic current in the tissue and is defined as:

𝑖𝑖𝑜𝑛 = 𝑘𝑐1 (𝑉𝑚 − 𝐵) [𝑎 −

(𝑉𝑚 − 𝐵)
(𝑉𝑚 − 𝐵)
] [1 −
] + 𝑘𝑐2 𝑢(𝑉𝑚 − 𝐵)
𝐴
𝐴

(2)

a, b, c1, c2, c3, d, e, k, A and B are parameters which describe the electrical attributes of
the tissue. The parameters were assigned values as in a previous study by Sovilj et al
[27].
In this study we assume the fibers are straight and aligned parallel to Cartesian xaxis. Heterogeneous tissue was represented by circular regions of low conductivities in
sizes ranging between 2 and 8 mm. The conductivities inside the patches of
heterogeneity were at least 100 fold lower than the conductivities in the rest of the tissue.
Zero flux boundary conditions were used along all external boundaries in the
intercellular space. In the extracellular space all external boundaries except the bottom
edge (designated as ground) were subjected to zero flux boundary conditions. The model
parameters and initial conditions are summarized in tables 3-1 and 3-2.
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Table 3.1: Model Parameters.
Parameter
Homogeneous
Tissue
Heterogeneous
Patch

a

b

c1

c2

d

e

A
(mV)

B
(mV)

k
(1/s)

six
(mS/m)

siy
(mS/m)

sex
(mS/m)

sey
(mS/m)

0.13

0

2.6

1

1

0.0132

140

-85

1000

8

0.8

6

4

0.13

0

2.6

1

1

0.0132

140

-85

1000

0.08

0.008

0.06

0.04

Table 3.2 Initial Conditions.
Ve (V)

Vi (V)

u (1/s)

0

-0.085

9

3.2.2 Initiation of reentry
A single spiral wave was initiated by cross-field stimulation using two stimuli S1
and S2 as shown in figure 3-1[19]. S1 was applied for duration of 20 ms and S2 for
duration of 50 ms with a 30 ms gap between them. This resulted in sustained reentry.

Figure 3.1: Initiation of reentry. (A) Location of reentry initiation stimuli, S1 & S2, and
termination stimuli, S3 & S4, in the geometry. (B) Reentry initiation stimuli amplitude
and duration. S1: 200 – 220 ms; S2: 240 – 300 ms.
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3.2.3 Application of the termination stimulus
The termination stimulus was applied at the stimulation electrodes (shown as S3 and
S4 in figure 3-1(A)) after the reentry was sustained. The timing and duration of the
termination pulse was varied to determine stimuli that are suitable for the cessation of
reentry. The size of the electrodes was also varied.
3.2.4 Finite Element Analysis
The simulations were carried out using COMSOL Multiphysics v4.3b package for
finite element analysis, on an Intel core i7-XPS 8100 PC with a processor speed of 2.93
GHz.
The mesh used consisted of 13996 elements to represent the total area of 10000 mm2.
The maximum element size was 3.7 mm in the homogeneous tissue and was set to 0.1
mm along the boundary of the heterogeneous patch to eliminate any meshing errors due
to different conductivity values on either side of the boundary. The simulation time for
each execution of the model was about 45 minutes. Further reduction in maximum
boundary element size along patch boundary to 0.01 mm did not change the spatial
distribution of Vm.
3.3 Results
The influence of macroscopic patches of heterogeneity on the termination of reentry
with an external stimulus was studied. A single spiral wave reentry was initiated by
cross-field stimulation using two stimuli as shown in figure 3-1. Once the reentry was
sustained, the termination stimulus was applied via the electrodes. The size and position
of the heterogeneity patch, size of the electrodes, and, the amplitude, duration and timing
of the termination stimulus were all found to have an effect on the termination of reentry.
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The effect of smooth and sharp transition of conductivities along the patch boundary was
also compared.
3.3.1 Termination of reentry with and without heterogeneity
The termination stimulus consisted of a single pulse applied to the tissue via
stimulation electrodes once the reentry was sustained. Irrespective of the amplitude,
duration and timing of the stimulus, the single spiral wave reentry could not be
terminated in homogeneous tissue. In the reentry model with a single 6 mm patch at the
center of the geometry, the reentry was terminated by a termination stimulus of amplitude
500 A/m3 and duration of 100 ms applied at 500 ms. Figure 3-2 shows the comparison of
the effect of termination stimulus on homogeneous and heterogeneous tissue. Figure 3-3
compares the transmembrane potential at a point in the tissue over time in the two cases.
The sizes of the stimulus electrodes used were 12 x 4 mm.
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Figure 3.2: Life cycle of the reentry. Spatial distribution of transmembrane potential
(Vm) in (A) homogenous tissue and (B) tissue with a 6 mm central heterogeneous patch.
Panels are arranged top to bottom, from the initiation of reentry (350 ms) at top 1st row,
to sustained reentry (490 ms) at 2nd row, followed by application of stimulus (550ms) at
3rd row. The last 4 rows (650 – 920 ms) demonstrate the effect of the termination
stimulus on the reentry. In column A the reentry is not terminated while in column B the
reentry is successfully terminated.
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Figure 3.2: Continued. Life cycle of the reentry. Spatial distribution of transmembrane
potential (Vm) in (A) homogenous tissue and (B) tissue with a 6 mm central
heterogeneous patch. Panels are arranged top to bottom, from the initiation of reentry
(350 ms) at top 1st row, to sustained reentry (490 ms) at 2nd row, followed by application
of stimulus (550ms) at 3rd row. The last 4 rows (650 – 920 ms) demonstrate the effect of
the termination stimulus on the reentry. In column A the reentry is not terminated while
in column B the reentry is successfully terminated.
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Figure 3.3: Transmembrane Potential Vm over the complete time span of the simulation
at the coordinates (50,70) mm. (A) Homogeneous tissue: Reentry sustained even after
application of termination stimulus at 550 ms. (B) Heterogeneous tissue: Reentry
terminated by the termination stimulus applied at 550 ms.

3.3.2 Effect of size of heterogeneity patch
The radius of a single, central patch of heterogeneous tissue was varied from 3 mm to
8 mm and the minimum amplitude of the termination stimulus required to terminate the
reentry at each patch size was determined. The stimulus amplitude increased as the radius
of the patch increased from 4 mm to 6mm as shown in figure 3-4. The sizes of the
stimulus electrodes used were 12 x 4 mm.
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Figure 3.4: Effect of heterogeneous patch size on termination stimulus amplitude. The
patch was centered at (50, 50) mm.

3.3.3 Effect of duration of termination stimulus
The duration of the termination stimulus was varied from 10 ms to 280 ms to study
the effect of duration on termination of reentry. The reentry was successfully terminated
at termination durations of 10, 20, 80, 90 and 100 ms for a reentry cycle length of 140
ms. The patch radius was 6 mm and the stimulus electrodes measured 12 x 4 mm. The
minimum stimulus amplitude required to terminate the reentry was constant at 500 A/m3.
Table 3-3 lists the observations for all time durations.
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Table 3.3: Effect of duration of termination stimulus.
Stimulus Interval (s) Stimulus Duration (ms) Outcome*
0.5-0.51
0.5-0.52
0.5-0.53
0.5-0.54
0.5-0.55
0.5-0.56

10
20
30
40
50
60

1
1
0
0
0
0

0.5-0.57
0.5-0.58

70
80

0
1

0.5-0.59
0.5-0.60
0.5-0.61
0.5-0.62
0.5-0.63
0.5-0.64
0.5-0.68
0.5-0.72

90
100
110
120
130
140
180
220

1
1
0
0
0
0
0
0

0.5-0.78

280

0

* Outcome: 1 = successful termination of reentry; 0 = failure to terminate reentry.

3.3.4 Effect of timing of termination stimulus
The duration of the stimulus was set to 20 ms while the timing of the stimulus was
varied from 0.5 to 0.69 s. The results (table 3-4) show that successful termination of
reentry was possible only when the termination stimulus was applied in the first 20 ms
window during the diastolic period of the tissue (i.e. the timing of the stimulus should
coincide with the valleys of the transmembrane potential distribution shown in fig 3-3).
Fig 3-5 (A)-(D) show the spatial distribution of transmembrane potential Vm at different
times illustrating the successful termination of reentry after the application of a
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termination stimulus at the appropriate timing. Here again, the patch radius was 6 mm
and the stimulus electrodes measured 12 x 4 mm. The minimum stimulus amplitude
required to terminate the reentry was constant at 500 A/m3.

Table 3.4: Effect of timing of termination stimulus.
Stimulus Interval (s) Outcome*
0.5 - 0.52
0.51 - 0.53

1
0

0.52 - 0.54
0.53 - 0.55
0.54 - 0.56
0.55 - 0.57
0.56 - 0.58
0.57 - 0.59
0.58 - 0.6
0.59 - 0.61
0.6 - 0.62

0
0
0
0
0
0
0
0
0

0.61 - 0.63
0.62 - 0.64
0.63 - 0.65
0.64 - 0.66
0.65 - 0.67

0
0
0
1
0

0.66- 0.68

0

0.67- 0.69

0

* Outcome: 1 = successful termination of reentry; 0 = failure to terminate reentry.
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Figure 3.5: Effect of timing on termination of reentry. Spatial distribution of
transmembrane potential (Vm) in V: (A) at t = 0.44s, prior to application of termination
stimulus, (B) at t = 0.53s, just after application of termination stimulus, (C) at t = 0.68s,
reentry turning into flat wavefronts and (D) at t = 1.2s, reentry successfully terminated.

3.3.5 Effect of electrode size
The electrode size had an effect on the minimum amplitude of termination stimulus
required for successful termination of reentry. The heterogeneous patch radius was 6 mm
and was located at the center for the geometry. Figure 3-6 illustrates the effect of
electrode size on termination amplitude. The width of the electrode (x-direction) was
constant at 4 mm and the length of the electrode (y-direction) was varied from 4 mm to
100 mm. The amplitude of the termination stimulus was lowest for electrode lengths
between 12 and 14 mm and increased by a maximum of 8 to 10 fold both when the
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electrode size was reduced and increased. When the length of the electrode was equal to
the length of the tissue (100 mm), the reentry could not be terminated, irrespective of the
amplitude of the termination stimulus.
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Figure 3.6: Effect of electrode size on termination of reentry.

3.3.6 Effect of location of heterogeneity patch
A single patch with a radius of 6 mm was positioned at different locations in the
geometry as shown in the figure 3-7 (A) - (D). The electrodes measured 4 x 12 mm for
different patch sizes tested. Next, multiple heterogeneous patches were introduced into
the geometry as shown in figure 3-7 (E) and (F). Termination of reentry was possible for
2 of the 4 single patch locations tested. It was not possible to terminate reentry in the case
with multiple patches, when the patches were spaced away from each other (fig 3-7 (E)).
When the multiple patches were closer together the reentry in the atrial tissue was
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successfully terminated (fig 3-7 (F)). Table 3-5 shows the outcome of the termination
stimulus at different patch locations.

Table 3.5: Effect of location of heterogeneity on termination of reentry.
Patch Location

Figure

Outcome*

Single Patch @ (50,50)

3.6(A)

1

Single Patch @ (50,83)

3.6(B)

1

Single Patch @ (50,15)

3.6(C)

0

Single Patch @ (85,90)

3.6(D)

0

Multiple Patches

3.6(E)

0

Multiple Patches

3.6(F)

1

* Outcome: 1 = successful termination of reentry; 0 = failure to terminate reentry.
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Figure 3.7: Effect of heterogeneity patch location and number. (A) Patch (r=6mm)
centroid located at (50, 50) mm. (B) Patch (r=6mm) centroid located at (50,83) mm. (C)
Patch (r=6mm) centroid located at (50,15) mm. (D) Patch (r=6mm) centroid located at
(85,90) mm. (E) and (F) Multiple patches of heterogeneity. (E) Patch radius = 7 mm at
(50,50) mm. Patch radius = 5 mm at (30,90) mm. Patch radius = 3 mm at (75,80) mm.
Patch radius = 8 mm at (60,10) mm. (F) Patch radius = 7 mm at (50,50) mm. Patch radius
= 5 mm at (50,63) mm. Patch radius = 3 mm at (39,52) mm. Patch radius = 6 mm at
(38,40) mm.
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3.3.7 Effect of anisotropy ratio
This study models unequal anisotropy ratios in the extracellular and intracellular
domains of the bidomain model. In all the results discussed so far, though the
conductivity values inside the patch were set to low values, the ratio of anisotropy was
maintained constant in the entire tissue. In this section however, the anisotropy ratios
inside the region used to represent heterogeneity were varied to study any effect of
anisotropy on the amplitude of the termination stimulus. Irrespective of lower, higher or
equal anisotropy ratio in the heterogeneity patch with respect to conductivities in the rest
of the tissue, the minimum amplitude for successful termination of reentry remained the
same for a given patch size and electrode size as long as the conductivities in the patch
were lower at least by two orders of magnitude in the patch as compared to the rest of the
tissue.
3.3.8 Smooth transition of conductivity values in the heterogeneity patch
In the previous test results extracellular and intracellular tissue conductivities were set
at a higher value outside the heterogeneity patch and 100 fold lower in the region of
heterogeneity to represent physiological areas of heterogeneity like infiltrated fat in atrial
tissue. There was a sharp change in conductivity values at the boundary of the patch. In
order to test a more realistic situation of gradual changes in tissue properties from one
area to the next, we simulated a gradual reduction of tissue conductivities over 0.1 mm.
Each of the extracellular and intracellular conductivity components in directions parallel
and perpendicular to the fiber axis were assigned a value defined by
σ (x,y) = σ min+ (σ max - σ min) * step(r), where step(r) is a step function with values in the
interval [0,1] and r = √(x2+y2), σ min and σ max are the respective conductivity values

45

inside and outside the patch respectively. For a 6 mm patch and electrodes of size 4 x 12
mm, the amplitude of the termination stimulus required to terminate reentry in tissue with
smooth transition of conductivities was almost twice that of the tissue with a sharp
transition of conductivities.
3.4 Discussion
Cellular and microscopic discontinuities in cardiac tissue, including gap junctions,
intercellular clefts, interlaminar clefts, electroporation and coronary vasculature have
been shown to support defibrillation [9], [11], [12], [14], [15]. However, the role of larger
patches of heterogeneities, such as, pulmonary vein-atrial junction, which have been
shown to initiate and attract reentries [20], [21], on defibrillation have not been explored.
Furthermore, only recently, infiltrated atrial fat was measured and estimated to be in the
size range of a few millimeters [22]. The present study explores whether or not
macroscopic heterogeneity influence defibrillation in a similar way as smaller
discontinuities and aids the defibrillation process. The research also examines through
simulation if there is a correlation between size of the heterogeneous tissue and
defibrillation stimulus amplitude.
Application of an external stimulus resulted in one of four outcomes: shift in the
position of reentry, break-up of the single reentry into multiple rotors, break-up of the
reentrant spiral wavefront into planar wavefronts swept to the boundaries or no effect. In
cases where termination was observed the spiral wavefront split into planar wavefronts at
the heterogeneous patch and these planar wavefronts were swept to the top and bottom
edges of the tissue. In the case of homogeneous tissue with no heterogeneous areas, the
reentry was not fixed at any location and was free to move about the entire space. As a
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result, it could not be terminated with the termination stimulus which was applied at a
fixed location.
When the size of the heterogeneous patch was 2mm or smaller reentry could not be
initiated with the S1-S2 cross-field stimulation protocol. We believe that the reason for
this is that the surface was not large enough for the reentry to pin itself to the
heterogeneous patch. Hence the initiation wavefront split into planar wavefronts right at
initiation and drifted towards the top and bottom edges of the tissue.
Trayanova et al. demonstrated in a previous study that while point electrodes were
able to successfully terminate reentry in a 2D model, line electrodes along parallel edges
of the tissue were incapable of dissipating the spiral wave [10]. Our results show a similar
effect where electrodes of sizes up to a length of 64 mm along the length of the side walls
could terminate reentry but larger electrodes between 64 and 100 mm (the tissue length)
were not effective.
This model shows that overly complex cardiac models may not be necessary to study
the electrical behavior of active cardiac tissue, as has been suggested in the past [28]. The
model being easily replicable can be expanded based on the need to include structural and
ionic details, now that the basic mechanism of the effect of macroscopic heterogeneity on
defibrillation has been established.
The limitations of this study are that the fibrous nature of the myocardial tissue was
not accounted for which is believed to have an effect on formation and termination of
reentries [9]. We assumed that the myocardial tissue is parallel to the cartesian x-axis to
reduce complexity in this basic model. Other cellular and micro-scale discontinuities
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were also ignored to keep the model computationally inexpensive and exclusively study
the role of macroscopic heterogeneity.
3.5 Conclusions
We have developed a computationally inexpensive 2D model of active cardiac tissue
that demonstrates the difference in electrical activity during defibrillation with and
without macroscopic patches of heterogeneity. This model provides insight into the
effects of size and location of patches of heterogeneity, timing and duration of the
defibrillation stimulus and size of the stimulation electrodes on the success or failure to
terminate sustained reentry. The novelty of this study is that it is the first of its kind to
determine the role of areas of heterogeneity in the size range of a few millimeters to a
centimeter using simplistic ionic models. These patches mimic areas such as, pulmonary
vein atrial junction and infiltrated atrial fat. We find from this study that simple models
can be very insightful, while the computational overload is reduced by eliminating
structural and ionic complexity
The simulation results showed that defibrillation was successful in heterogeneous
tissue with a single central patch since the reentry anchored onto the patch of
heterogeneity. In homogeneous tissue the reentry was free to meander about in the entire
tissue and hence defibrillation was unsuccessful. The amplitude of the termination
stimulus increased with size of the heterogeneity patch. Defibrillation was successful
only when the stimulus was applied in the diastolic phase of the tissue.
This model is a platform for future studies on heterogeneity and its effects on
defibrillation. There has been a lot of interest in finding low energy methods of
defibrillation for atrial fibrillation [29]–[31]. Previous studies have found that
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macroscopic heterogeneities like the pulmonary vein-atrial junction attracts rotors
generated elsewhere besides being a source itself [20], [21]. Macroscopic heterogeneities
could possibly be recruited effectively using an appropriate, patient specific defibrillation
protocol towards lower energy defibrillation. This model can be used to study different
defibrillation protocols and evaluate if defibrillation can be achieved at thresholds below
pain threshold and make implantable atrial defibrillation feasible.
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CHAPTER 4
CONCLUSIONS
The objectives of this research initiative were (1) to study the effect of macroscopic
patches of heterogeneity on propagation, (2) to determine whether or not these
heterogeneities affect termination of reentry and (3) to analyze the effect of patch size
and location, electrode size and amplitude of termination stimulus on the termination of a
single spiral reentrant wavefront.
Computer simulations were performed using a two dimensional finite element model
of a sheet of cardiac tissue. On the introduction of macroscopic patches of heterogeneity
into a normal propagation model, the rate and rhythm of propagation were affected.
Ectopic atrial impulses were observed; however, reentrant activity was not seen. The
results also indicate that a minimum gradient of conductivity values inside and outside
the heterogeneous region is required to produce fibrillatory behavior.
The next set of simulations was aimed at examining the effect of tissue heterogeneity
on termination of a single spiral wave reentry, induced by the commonly used crossstimulation protocol. The reentry was successfully terminated in heterogeneous tissue
where the heterogeneity patch pinned the spiral wave. In homogeneous tissue the
reentrant activity could not be nullified. The results show a positive correlation between
patch size and amplitude of the termination stimulus. The timing of the stimulus was
found to be critical to success.
AF is an important clinical problem which has been studied for several decades and
yet not completely understood. Methodologies to understand the cause of AF at a patient
specific level can help arrive at treatment methods appropriate to the patient rather than
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generalized approaches. Experimental and clinical studies are invaluable; however, it is
very difficult to exactly pin point the location of sources of ectopic activity
experimentally because of the complexity in structure and function. Hence computational
studies are essential and insightful tools. Here, complex problems can be broken up into
smaller, easier to analyze cases and tackled separately before being considered all
together. This model is a novel framework of a computationally inexpensive model for
further studies on the role of heterogeneities in the genesis and termination of atrial
arrhythmia.
Further studies with models incorporating detailed geometries may help predict the
risk of AF in people with normal sinus rhythm and suggest preventative measures.
Heterogeneous cardiac tissue could possibly be recruited effectively using patient specific
defibrillation protocols towards lower energy defibrillation and implantable atrial
defibrillation. This will not only result in reduced hospitalization costs but also improve
quality of life in patients with AF.
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